CD69 Monoclonal Antibody (H1.2F3), Brilliant Ultra Violet™ 496, eBioscience™, Invitrogen™
Armenian Hamster Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
CD69
Concentration
0.2 mg/mL
Classification
Monoclonal
Form
Liquid
Regulatory Status
RUO
Formulation
PBS with BSA and 0.09% sodium azide; pH 7.2
Gene Alias
5830438K24Rik; Activation inducer molecule; activation inducer molecule (AIM/CD69); AI452015; AIM; BL-AC/P26; CD69; CD69 antigen; CD69 antigen (p60, early T-cell activation antigen); CD69 molecule; CLEC2C; C-type lectin domain family 2 member C; C-type lectin domain family 2, member C; EA1; early activation antigen CD69; early lymphocyte activation antigen; early T-cell activation antigen p60; GP32/28; leukocyte surface antigen Leu-23; MLR-3; VEA; Very Early Activation Antigen
Gene Symbols
CD69
Primary or Secondary
Primary
Content And Storage
4° C, store in dark, DO NOT FREEZE!
Gene
CD69
Clone
H1.2F3
Applications
Flow Cytometry
Conjugate
Brilliant Ultraviolet 496
Host Species
Armenian Hamster
Target Species
Mouse
Gene Accession No.
P37217
Gene ID (Entrez)
12515
Isotype
IgG
Purification Method
Affinity chromatography
Product Type
Antibody
Related Products
Description
- CD69 (AIM, Active Inducer Molecule) is a gp28/34 disulfide bonded homodimer with a molecular weight of 60 kDa under non-reducing conditions
- CD69 contains one or two N linked oligosacaride and the molecule is present on activated platelets
- In normal peripheral blood a variable percentage of cells express the CD69 antigen, and it is involved in lymphocyte signal transduction
- Expression CD69 is induced upon activation of T lymphocytes, and may play a role in proliferation
- Furthermore, the protein may act to transmit signals in natural killer cells and platelets
- Alternative splicing results in multiple transcript variants of CD69
- Diseases associated with CD69 dysfunction include coccidiodomycosis and asthma.